Fort Worth Clinical Sciences Working Group
1 clinical trials · Sponsor
◉ Watch Fort Worth Clinical Sciences Working Group
| Record | Firm | Date |
|---|---|---|
| Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients (NCT05013034) | Fort Worth Clinical Sciences Working Group | 2021-10-15 |
Track Fort Worth Clinical Sciences Working Group automatically
Every clearance here is in the API, with alerts when new ones post.